Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MITF | O75030 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | SMO | Q99835 | 1/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15839178 | 0.83 | CYP17A1 (0.45) | CYP1A2CYP11B1CYP11B2GSK3BFLT3 | |
| SCHEMBL11888511 | 0.81 | CYP11B1 (0.43) | ALDH1A1LMNAMITFCYP1A2CYP3A4 | |
| SCHEMBL16574155 | 0.80 | TP53 (0.43) | ALDH1A1LMNATP53CYP11B1CYP11B2 | |
| SCHEMBL23840290 | 0.78 | PDE10A (0.45) | ALDH1A1LMNAKDM4EMITFCYP1A2 | |
| SCHEMBL14688369 | 0.78 | CYP11B1 (0.40) | KDM4ECYP1A2CYP11B1CYP11B2PDE10A | |
| SCHEMBL14688616 | 0.78 | PDE10A (0.43) | KDM4ECYP1A2HTTTP53CYP11B1 | |
| SCHEMBL1135647 | 0.78 | SCN9A (0.49) | SMOCYP11B1CYP11B2MAPK14 | |
| SCHEMBL29573544 | 0.78 | SCN9A (0.49) | SMOCYP11B1CYP11B2MAPK14 | |
| SCHEMBL2188830 | 0.78 | CYP11B1 (0.48) | TSHRALDH1A1LMNAKDM4ECYP1A2 | |
| SCHEMBL3020579 | 0.78 | PDE10A (0.43) | LMNACYP1A2CYP11B1CYP11B2PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11818946-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-14 | — | — | US | disclosed |
| US-11765966-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
| US-20230276696-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2023-08-31 | — | — | US | disclosed |
| US-20230270003-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-24 | — | — | US | disclosed |
| US-11685756-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230200211-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-22 | — | — | US | disclosed |
| US-11683981-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-20 | — | — | US | disclosed |
| US-11672165-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-06 | — | — | US | disclosed |
| US-10680187-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-06-09 | — | — | US | disclosed |
| US-20190189935-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-06-20 | — | — | US | disclosed |
| US-20180130962-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-10 | — | — | US | disclosed |
| US-20180130962-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-10 | — | — | US | disclosed |
| US-9771375-B2 | Indazole compounds useful as ketohexokinase inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2017-09-26 | — | — | US | disclosed |
| CN-102939283-B | Indazole compounds useful as ketohexokinase inhibitors | JANSSEN PHARMACEUTICA NV | 2015-06-03 | — | — | CN | disclosed |
| US-20140336170-A1 | INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS | JANSSEN PHARMACEUTICA NV (US) | 2014-11-13 | — | — | US | disclosed |
| US-8822447-B2 | Indazole compounds useful as ketohexokinase inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2014-09-02 | — | — | US | disclosed |
| CN-102939283-A | Indazole compounds useful as ketohexokinase inhibitors | JANSSEN PHARMACEUTICA NV | 2013-02-20 | — | — | CN | disclosed |
| US-20110263559-A1 | INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2011-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685756-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OPRD1 | TSHR 3424/4885ALDH1A1 2254/4885LMNA 3673/4885 |
| US-20140336170-A1 | INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS | KHK, GCK, GCKR | TSHR 3688/4885ALDH1A1 1451/4885LMNA 4091/4885 |
| US-20190189935-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OR10J3, OXER1, CHRM4 | TSHR 196/4885ALDH1A1 1404/4885LMNA 2695/4885 |
| US-20180130962-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TYR, ORC3, LEF1 | TSHR 2533/4885ALDH1A1 303/4885LMNA 1521/4885 |
| US-11818946-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, AOC3 | TSHR 3108/4885ALDH1A1 705/4885LMNA 572/4885 |
| US-20230270003-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, CHRM1, OSBPL8 | TSHR 1499/4885ALDH1A1 424/4885LMNA 648/4885 |
| US-20230200211-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OPRM1, OCIAD1 | TSHR 1460/4885ALDH1A1 412/4885LMNA 701/4885 |
| US-10680187-B2 | Organic electroluminescent materials and devices | TYR, ORC3, LEF1 | TSHR 2533/4885ALDH1A1 303/4885LMNA 1521/4885 |
| US-20230276696-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, PORCN | TSHR 4754/4885ALDH1A1 3156/4885LMNA 2148/4885 |
| US-11683981-B2 | Organic electroluminescent materials and devices | OXER1, CHRM1, OSBPL8 | TSHR 1499/4885ALDH1A1 424/4885LMNA 648/4885 |
| US-11765966-B2 | Organic electroluminescent materials and devices | L1CAM, EPCAM, EPM2A | TSHR 4074/4885ALDH1A1 1028/4885LMNA 572/4885 |
| US-20110263559-A1 | INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS | KHK, GCK, GCKR | TSHR 3688/4885ALDH1A1 1451/4885LMNA 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.